ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer
Min Ho Choe(Korea Institute of Radiological and Medical Sciences), Jae‐Sung Kim(Korea Institute of Radiological and Medical Sciences)
Cited by 72
Related Papers
miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP
|Cell Death and Disease|2018|40
MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells
|BMC Cancer|2018|40
MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer
|Frontiers in Oncology|2020|24
Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3
|Cellular and Molecular Immunology|2023|22